MediWound Ltd (NASDAQ: MDWD) has reported E.P.S. of $-0.24 for its third fiscal quarter (ending September 30) versus $-0.13 for the same period a year ago. Relative to the consensus estimate of $-0.39, this was a premium of $0.15. E.P.S. were $-1.74 for the latest four quarters through September 30 versus $-0.53 for the same period a year ago.
Recent Price Action
On 11/21/23, MediWound Ltd (NASDAQ: MDWD) stock declined by -1.9%, closing at $8.40. The stock has risen 6.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
MDWD is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
MediWound has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. MediWound has a poor Power Rating of 23 and a very low Appreciation Score of 3, leading to the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment